"The physicians of Oregon Neurology Associates are the region's leading experts in comprehensive and thorough neurological care. While neurology is the sole focus of our highly trained neurologists, many of them have advanced subspecialty education in such areas as child neurology, epilepsy, headache medicine, movement disorders, neuromuscular disease, and neuro-ophthalmology. They also have special interest in Parkinson's disease, multiple sclerosis, stroke, and other conditions that are difficult to diagnose."

During the past decade, Oregon Neurology Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oregon Neurology Associates" #1 sponsor was "GlaxoSmithKline" with 2 trials, followed by "Novartis" with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Green Valley (Shanghai) Pharmaceuticals Co., Ltd." with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oregon Neurology Associates" #1 collaborator was "Bausch Health Americas, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Oregon Neurology Associates" are "Multiple Sclerosis" (2 trials), "Alzheimer Disease" (1 trials), "Epilepsies, Partial" (1 trials), "Epilepsy" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "Oregon Neurology Associates" in a lesser frequency.

Most popular intervention types in "Oregon Neurology Associates" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ezogabine: USAN Retigabine (International Nonproprietary Name)" (1 trials), "Fingolimod" (1 trials), "Fingolimod 0.5 mg" (1 trials) and "Fingolimod 1.25 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oregon Neurology Associates" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Oregon Neurology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Oregon Neurology Associates, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oregon Neurology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".